# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-22-005561
Filing Date
2022-02-28
Accepted
2022-02-28 08:44:06
Documents
15
Period of Report
2022-02-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 59787
2 |  | ex3-1.htm | EX-3.1 | 12213
3 |  | ex99-1.htm | EX-99.1 | 10913
4 |  | ex99-1_001.jpg | GRAPHIC | 627092
| Complete submission text file | 0001493152-22-005561.txt |  | 1127960

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | clsn-20220228.xsd | EX-101.SCH | 3030
6 | XBRL LABEL FILE | clsn-20220228_lab.xml | EX-101.LAB | 34476
7 | XBRL PRESENTATION FILE | clsn-20220228_pre.xml | EX-101.PRE | 22593
9 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3828

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 22684109
SIC: 2834 Pharmaceutical Preparations